Genetic Variation in OCT1 and Response to Metformin
NCT00588172
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
No funding
Conditions
Type 2 Diabetes
Interventions
DRUG:
Metformin
Sponsor
Mayo Clinic